IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
Bioinformatics & Bioanalysis
Investors
Latest news // Archive
-
Press releases
IntegraGen announces leading U.S. cancer center to use MERCURY™ cloud-based tool for oncology sequencing data interpretation and reporting
-
News
COVID-19 update: IntegraGen remains committed to meeting our customers needs
-
Press releases
IntegraGen renews its agreement with the Institut Pasteur related to high-throughput sequencing for microbiology